311 West 24th Street Suite 401, Erie, PA 16502
814-455-7591

MACULAR DEGENERATION




macularMacular degeneration is the number one cause of blindness in the United States. It occurs when the macula -- a part of the retina in the back of the eye that ensures that our vision is clear and sharp -- degrades or "degenerates," causing a progressive loss of vision.

The "dry" form of macular degeneration has no treatment, but the"wet" form may be helped by laser procedures if it is detected early. Because of this, and because vision lost to the disease is irrecoverable, regular eye exams are highly recommended. Certain vitamins and minerals may also aid in slowing or preventing vision loss.

Symptons often associated with macular degeneration include:

  • A gradual loss of ability to see objects clearly
  • A gradual loss of color vision
  • Distorted vision
  • A dark or empty area appearing in the center of the vision

Avastin Treatment for Macular Degeneration

Avastin™ (FDA 2004):
Avastin was originally used for cancer patients but is now used to treat wet macular degeneration and works by inhibiting growth of abnormal blood vessels in the back of the eye.

The objective of the Avastin™ is ultimately to prevent further vision loss. Some patients have reported some regained vision but the medication should not be expected to restore vision that has already been lost due to macular degeneration.

Avastin and Lucentis injections are referred to as intravitreal injections. This implies that the injection is placed directly into the vitreous of the eye. After your eyes have been treated with topical eye drops and 4% Lidocaine, Betadine may be used around the eyelids to prevent infections. Once the lid speculum is in place the injection can begin. After the injection the eye doctor will ask you if you can see his or her hands or light. Your eye doctor may also measure your intraocular eye pressure before you leave the office. These injections will need to be repeated every four to five to six weeks.

Lucentis Injections for macular degeneration

Lucentis is a prescription medication for the treatment of patients with wet macular degeneration. As mentioned earlier in on this page wet macular degeneration involves the leaking of blood vessels onto the retina. After receiving FDA approval in June of 2006 Lucentis has become a guiding light source for patients once facing blindness.

Prior to receiving your Lucentis injection your eye will be prepped and cleaned in order to prevent any type of infection. Our retina specialists will then numb your eye to limit any discomfort. Patients do report slight pressure on the eye. Once the injection has passed the pressure will subside.

 

"The laser corrective surgery is probably one of the best decisions I have made in my lifetime. I wore glasses for 34 years, and it is truly a blessing not to wear them anymore. The procedure is short and virtually painless. As a person who has had this done I would recommend laser surgery to anyone who is a candidate and who can afford it. Dr. Haverly's staff was very, very professional and courteous. It is truly a miracle. Thank you."
Mark Jordanm, Coordinator, age 39

"I had laser refractive surgery because I did not want to bother with contacts. I like being able to see clearly when I wake up in the morning and not have to fumble around for glasses. It's wonderful being able to see objects in the distance without aid. I highly recommend Laser Eye Surgery of Erie. The surgery was quick and painless. Dr. Haverly, Dr. Gellis, and the office staff have been wonderful through this experience."
Joanne Troutman, Clerical Worker, age 40

Take our online LASIK Self Evaluation to determine if you are a candidate for iLASIK.

See the world more clearly with Lifestyle Lenses.